Reciprocal regulation of cholesterol excretion in apolipoprotein E-null mice by angiotensin II type 1 and type 2

Masaru Iwai1, Hisako Sone, Harumi Kanno

  • 1Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University Graduate School of Medicine, Shitsukawa, Tohon, Ehime, Japan.

Life Sciences
|January 22, 2013
PubMed
Abstract

Insights

Angiotensin (AT) receptor deficiency impacts cholesterol excretion. AT(1) receptor deficiency increases fecal cholesterol, while AT(2) receptor deficiency decreases it, suggesting reciprocal regulation in high-cholesterol conditions.

Area of Science:

  • Cardiovascular Research
  • Metabolic Regulation
  • Pharmacology

Background:

  • Atherosclerosis is a complex disease involving lipid metabolism.
  • The renin-angiotensin system, including AT(1) and AT(2) receptors, plays a role in cardiovascular function.
  • Understanding the role of these receptors in cholesterol homeostasis is crucial for managing atherosclerosis.

Purpose of the Study:

  • To investigate the effects of AT(1) and AT(2) receptor deficiency on cholesterol intake and excretion.
  • To elucidate the reciprocal roles of AT(1) and AT(2) receptors in cholesterol metabolism during high-cholesterol diet conditions.

Main Methods:

  • Utilized apolipoprotein E-null (ApoEKO) mice, a model for atherosclerosis.
  • Generated AT(1)a/ApoEKO and AT(2)/ApoEKO mice to study receptor deficiency.
  • Administered a high-cholesterol diet (HCD) and analyzed plasma, fecal, and bile cholesterol levels.
  • Examined liver cholesterol content and gene expression of HMG-CoA reductase and LDL receptor.
  • Investigated the effect of an AT(1) receptor blocker (irbesartan) on cholesterol excretion in ApoEKO mice.

Main Results:

  • AT(1)a/ApoEKO mice showed lower plasma cholesterol and higher fecal/bile cholesterol compared to ApoEKO mice.
  • AT(2)/ApoEKO mice exhibited higher plasma cholesterol and lower fecal/bile cholesterol.
  • Liver cholesterol content and key enzyme expression remained unchanged among groups.
  • Irbesartan treatment increased bile cholesterol and tended to increase fecal cholesterol excretion in ApoEKO mice on HCD.

Conclusions:

  • AT(1) and AT(2) receptor stimulation reciprocally regulate cholesterol excretion into bile and feces.
  • These receptors play a significant role in cholesterol homeostasis, particularly under conditions of cholesterol overload.
  • Targeting AT(1) receptors may offer a therapeutic strategy for enhancing cholesterol excretion in atherosclerosis.

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...